Prasanna R Kolatkar

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 7

Top Topics

Breast Cancer Cells

Endoplasmic Reticulum

Capillary Electrophoresis

Top Venues

Protein science : a publication of the Protein Society

The FEBS journal

This page only lists publications with an associated author ORCID identifier.

Publications

Zeyaul Islam, Nishant N Vaikath, Issam Hmila, Omar M A El-Agnaf, Prasanna R Kolatkar
Structural insights into the unique recognition module between α-synuclein peptide and nanobody. Protein science : a publication of the Protein Society 33 (2) (2024)
Zeyaul Islam, Nishant N Vaikath, Issam Hmila, Omar M A El-Agnaf, Prasanna R Kolatkar
Structural insights into the unique recognition module between α-synuclein peptide and nanobody. Protein science : a publication of the Protein Society 33 (2) (2024)
Zeyaul Islam, Nishant N Vaikath, Issam Hmila, Omar M A El-Agnaf, Prasanna R Kolatkar
Structural insights into the unique recognition module between α-synuclein peptide and nanobody. Protein science : a publication of the Protein Society 33 (2) (2024)
Zeyaul Islam, Nishant N Vaikath, Issam Hmila, Omar M A El-Agnaf, Prasanna R Kolatkar
Structural insights into the unique recognition module between α-synuclein peptide and nanobody. Protein science : a publication of the Protein Society (2023)
Zeyaul Islam, Abdoulaye Diane, Namat Khattab, Mohammed Dehbi, Paul Thornalley, Prasanna R Kolatkar
DNAJB3 attenuates ER stress through direct interaction with AKT. PloS one 18 (8) (2023)
Zeyaul Islam, Nishant N Vaikath, Issam Hmila, Omar M A El-Agnaf, Prasanna R Kolatkar
Structural insights into the unique recognition module between α-synuclein peptide and nanobody. Protein science : a publication of the Protein Society (2023)
Issam Hmila, Nishant N Vaikath, Nour K Majbour, Daniel Erskine, Indulekha P Sudhakaran, Vijay Gupta, Simona S Ghanem, Zeyaul Islam, Mohamed M Emara, Houari B Abdesselem, Prasanna R Kolatkar, Devaya K Achappa, Tatiana Vinardell, Omar M A El-Agnaf
Novel engineered nanobodies specific for N-terminal region of alpha-synuclein recognize Lewy-body pathology and inhibit in-vitro seeded aggregation and toxicity. The FEBS journal 289 (15) (2022)